Atrial natriuretic peptide and osteopontin are useful markers of cardiac disorders in mice

Comparative Medicine

Volumn 57, Issue 6, 2007, Pages 546-553

  Schoensiegel, Frank ^a   Bekeredjian, Raffi ^a   Schrewe, Anja ^a,b   Weichenhan, Dieter ^a   Frey, Norbert ^a   Katus, Hugo A ^a   Ivandic, Boris T ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b Institute of Experimental Genetics   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ATRIAL NATRIURETIC FACTOR; DELTA SARCOGLYCAN; OSTEOPONTIN; PROTEIN; PROTEIN MYOZENIN 2; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; ECHOCARDIOGRAPHY; FEMALE; HEART DISEASE; HEART INFARCTION; MALE; MOUSE; NONHUMAN;

AGING; ANIMALS; ATRIAL NATRIURETIC FACTOR; BIOLOGICAL MARKERS; CARDIOMYOPATHIES; CARRIER PROTEINS; DISEASE MODELS, ANIMAL; FEMALE; HEART DISEASES; MALE; MICE; MICE, INBRED STRAINS; MICE, KNOCKOUT; MUSCLE PROTEINS; OSTEOPONTIN; PHENOTYPE; SARCOGLYCANS; SPECIES SPECIFICITY; VENTRICULAR REMODELING;

EID: 38049040784     PISSN: 15320820     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Aherrahrou Z, Axtner SB, Kaczmarek PM, Jurat A, Korff S, Doehring LC, Weichenhan D, Katus HA, Ivandic BT. 2004. A locus on chromosome 7 determines dramatic up-regulation of osteopontin in dystrophic cardiac calcification in mice. Am J Pathol 164:1379-1387.
2. Arnlov J, Evans JC, Benjamin EJ, Larson MG, Levy D, Sutherland P, Siwik DA, Wang TJ, Colucci WS, Vasan RS. 2006. Clinical and echocardiographic correlates of plasma osteopontin in the community: the Framingham Heart Study. Heart 92:1514-1515.
3. Chandrashekhar Y. 2005. Multifunctional role of osteopontin in ventricular remodeling. J Lab Clin Med 145:5-8.
4. Chen AA, Wood MJ, Krauser DG, Baggish AL, Tung R, Anwaruddin S, Picard MH, Januzzi JL. 2006. NT-proBNP levels, echocardiographic findings, and outcomes in breathless patients: results from the ProBNP Investigation of Dyspnoea in the Emergency Department (PRIDE) echocardiographic substudy. Eur Heart J 27:839-845.
5. de Bold AJ, Borenstein HB, Veress AT, Sonnenberg H. 1981. A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats. Life Sci 28:89-94.
6. Denhardt DT, Noda M, O'Regan AW, Pavlin D, Berman JS. 2001. Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survival. J Clin Invest 107:1055-1061.
7. Dietz JR. 1984. Release of natriuretic factor from rat heart-lung preparation by atrial distension. Am J Physiol 247:R1093-R1096.
8. Frey N, Barrientos T, Shelton JM, Frank D, Rutten H, Gehring D, Kuhn C, Lutz M, Rothermel B, Bassel-Duby R, Richardson JA, Karus HA, Hill JA, Olson EN. 2004. Mice lacking calsarcin-1 are sensitized to calcineurin signaling and show accelerated cardiomyopathy in response to pathological biomechanical stress. Nat Med 10:1336-1343.
9. Gailus-Durner V, Fuchs H, Becker L, Bolle I, Brielmeier M, Calzada-Wack J, Elvert R, Ehrhardt N, Dalke C, Franz TJ, Grundner-Culemann E, Hammelbacher S, Holter SM, Holzlwimmer G, Horsch M, Javaheri A, Kalaydjiev SV, Klempt M, Kling E, Kunder S, Lengger C, Lisse T, Mijalski T, Naton B, Pedersen V, Prehn C, Przemeck G, Racz I, Reinhard C, Reitmeir P, Schneider I, Schrewe A, Steinkamp R, Zybill C, Adamski J, Beckers J, Behrendt H, Favor J, Graw J, Heldmaier G, Hofler H, Ivandic B, Katus H, Kirchhof P, Klingenspor M, Klopstock T, Lengeling A, Muller W, Ohl F, Ollert M, Quintanilla-Martinez L, Schmidt J, Schulz H, Wolf E, Wurst W, Zimmer A, Busch DH, de Angelis MH. 2005. Introducing the German Mouse Clinic: open-access platform for standardized phenotyping. Nat Methods 2:403-404.
10. Graf K, Do YS, Ashizawa N, Meehan WP, Giachelli CM, Marboe CC, Fleck E, Hsueh WA. 1997. Myocardial osteopontin expression is associated with left ventricular hypertrophy. Circulation 96:3063-3071.
11. Hack AA, Lam MY, Cordier L, Shoturma DI, Ly CT, Hadhazy MA, Hadhazy MR, Sweeney HL, McNally EM. 2000. Differential requirement for individual sarcoglycans and dystrophin in the assembly and function of the dystrophin-glycoprotein complex. J Cell Sci 113:2535-2544.
12. Hall C, Aaberge L, Stokke O. 1995. In vitro stability of N-terminal proatrial natriuretic factor in unfrozen samples: an important prerequisite for its use as a biochemical parameter of atrial pressure in clinical routine. Circulation 91:911.
13. Itoh H, Nakao K, Sugawara A, Saito Y, Mukoyama M, Morii N, Yamada T, Shiono S, Arai H, Hosoda K. 1988. Gamma atrial natriuretic polypeptide (γANP)-derived peptides in human plasma: cosecretion of N-terminal γ ANP fragment and α ANP J Clin Endocrinol Metab 67:429-437.
14. Korff S, Riechert N, Schoensiegel F, Weichenhan D, Autschbach F, Katus HA, Ivandic BT. 2006. Calcification of myocardial necrosis is common in mice. Virchows Arch 448:630-638.
15. Krauser DG, Lloyd-Jones DM, Chae CU, Cameron R, Anwaruddin S, Baggish AL, Chen A, Tung R, Januzzi JL Jr. 2005. Effect of body mass index on natriuretic peptide levels in patients with acute congestive heart failure: a ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) substudy. Am Heart J 149:744-750.
16. Liaw L, Birk DE, Ballas CB, Whitsitt JS, Davidson JM, Hogan BL. 1998. Altered wound healing in mice lacking a functional osteopontin gene (spp 1). J Clin Invest 101:1468-1478.
17. Murry CE, Giachelli CM, Schwartz SM, Vracko R. 1994. Macrophages express osteopontin during repair of myocardial necrosis. Am J Pathol 145:1450-1462.
18. Nishikimi T, Maeda N, Matsuoka H. 2006. The role of natriuretic peptides in cardioprotection. Cardiovasc Res 69:318-328.
19. Richards AM, Troughton R, Lainchbury J, Doughty R, Wright S. 2005. Guiding and monitoring of heart failure therapy with NT-ProBNP: concepts and clinical studies. J Card Fail 11:S34-S37.
20. Sahn DJ, DeMaria A, Kisslo J, Weyman A. 1978. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 58:1072-1083.
21. Sam F, Xie Z, Ooi H, Kerstetter DL, Colucci WS, Singh M, Singh K. 2004. Mice lacking osteopontin exhibit increased left ventricular dilation and reduced fibrosis after aldosterone infusion. Am J Hypertens 17:188-193.
22. Satoh M, Nakamura M, Akatsu T, Shimoda Y, Segawa I, Hiramori K. 2005. Myocardial osteopontin expression is associated with collagen fibrillogenesis in human dilated cardiomyopathy. Eur J Heart Fail 7:755-762.
23. Singh K, Sirokman G, Communal C, Robinson KG, Conrad CH, Brooks WW, Bing OH, Colucci WS. 1999. Myocardial osteopontin expression coincides with the development of heart failure. Hypertension 33:663-670.
24. Stawowy P, Blaschke F, Pfautsch P, Goetze S, Lippek F, Wollert-Wulf B, Fleck E, Graf K. 2002. Increased myocardial expression of osteopontin in patients with advanced heart failure. Eur J Heart Fail 4:139-146.
25. Suezawa C, Kusachi S, Murakami T, Toeda K, Hirohata S, Nakamura K, Yamamoto K, Koten K, Miyoshi T, Shiratori Y. 2005. Time-dependent changes in plasma osteopontin levels in patients with anterior-wall acute myocardial infarction after successful reperfusion: correlation with left-ventricular volume and function. J Lab Clin Med 145:33-40.
26. Sundsfjord JA, Thibault G, Larochelle P, Cantin M. 1988. Identification and plasma concentrations of the N-terminal fragment of proatrial natriuretic factor in man. J Clin Endocrinol Metab 66:605-610.
27. Syed F, Diwan A, Hahn HS. 2005. Murine echocardiography: a practical approach for phenotyping genetically manipulated and surgically modeled mice. J Am Soc Echocardiogr 18:982-990.
28. Thibault G, Garcia R, Gutkowska J, Bilodeau J, Lazure C, Seidah NG, Chretien M, Genest J, Cantin M. 1987. The propeptide Asn1-Tyr126 is the storage form of rat atrial natriuretic factor. Biochem J 241:265-272.
29. Thibault G, Murthy KK, Gutkowska J, Seidah NG, Lazure C, Chretien M, Cantin M. 1988. NH2-terminal fragment of rat proatrial natriuretic factor in the circulation: identification, radioimmunoassay, and half-life. Peptides 9:47-53.
30. Trueblood NA, Xie Z, Communal C, Sam F, Ngoy S, Liaw L, Jenkins AW, Wang J, Sawyer DB, Bing OH, Apstein CS, Colucci WS, Singh K. 2001. Exaggerated left ventricular dilation and reduced collagen deposition after myocardial infarction in mice lacking osteopontin. Circ Res 88:1080-1087.
31. Xie Z, Singh M, Singh K. 2004. Osteopontin modulates myocardial hypertrophy in response to chronic pressure overload in mice. Hypertension 44:826-831.